Overview

Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease

Status:
Completed
Trial end date:
2016-05-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether pramipexole and bromocriptine are effective in the treatment of non-motor symptoms in Parkinson's Disease.
Phase:
Phase 4
Details
Lead Sponsor:
Sandoz
Treatments:
Bromocriptine
Pramipexole